Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Protalix BioTherapeutics ...

    AMEX: PLX · Real-Time Price · USD
    1.48
    -0.06 (-3.90%)
    At close: Aug 19, 2025, 1:54 PM

    Protalix BioTherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 19.76M 23.63M 17.11M 38.98M
    Short-Term Investments
    		 15.07M 20.93M 5.07M 38.98M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 462K 528K 1.27M 2.08M
    Receivables
    		 2.91M 5.27M 4.59M 3.44M
    Inventory
    		 21.24M 19.05M 16.8M 17.95M
    Other Current Assets
    		 596K 611K 536K 380K
    Total Current Assets
    		 60.08M 69.93M 44.88M 61.67M
    Property-Plant & Equipment
    		 10.02M 10.88M 9.64M 9.92M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 13.34M 14.5M 10.91M 12M
    Total Assets
    		 73.42M 84.43M 55.79M 73.67M
    Account Payables
    		 4.53M 4.32M 5.86M 6.99M
    Deferred Revenue
    		 n/a n/a 13.18M 8.55M
    Short-Term Debt
    		 n/a 21.66M 1.12M 1.21M
    Other Current Liabilities
    		 1.81M 4.94M 9.94M 13.14M
    Total Current Liabilities
    		 25.62M 45.53M 32.43M 33.18M
    Long-Term Debt
    		 n/a n/a 28.19M 27.89M
    Other Long-Term Liabilities
    		 559K 714K 1.64M 2.47M
    Total Long-Term Liabilities
    		 4.58M 5.33M 34M 46.52M
    Total Liabilities
    		 30.21M 50.87M 66.43M 79.7M
    Total Debt
    		 5.53M 26.28M 33.47M 33.47M
    Common Stock
    		 76K 73K 54K 46K
    Retained Earnings
    		 -378.39M -381.55M -389.86M -374.93M
    Comprehensive Income
    		 n/a n/a n/a 0.00
    Shareholders Equity
    		 43.21M 33.57M -10.64M -6.04M
    Total Investments
    		 15.07M 20.93M 5.07M 38.98M

    Add to Watchlist